Logo image of HSCS

HEARTSCIENCES INC (HSCS) Stock Fundamental Analysis

USA - NASDAQ:HSCS - US42254E3027 - Common Stock

3.03 USD
+0.03 (+1.17%)
Last: 11/18/2025, 4:30:01 PM
Fundamental Rating

2

Taking everything into account, HSCS scores 2 out of 10 in our fundamental rating. HSCS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of HSCS is average, but there are quite some concerns on its profitability. HSCS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HSCS had negative earnings in the past year.
HSCS had a negative operating cash flow in the past year.
HSCS had negative earnings in each of the past 5 years.
In the past 5 years HSCS always reported negative operating cash flow.
HSCS Yearly Net Income VS EBIT VS OCF VS FCFHSCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

HSCS has a Return On Assets of -136.22%. This is amonst the worse of the industry: HSCS underperforms 83.51% of its industry peers.
HSCS's Return On Equity of -279.15% is on the low side compared to the rest of the industry. HSCS is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA -136.22%
ROE -279.15%
ROIC N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSCS Yearly ROA, ROE, ROICHSCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

HSCS has a Gross Margin of 57.14%. This is comparable to the rest of the industry: HSCS outperforms 54.79% of its industry peers.
HSCS's Gross Margin has improved in the last couple of years.
HSCS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
HSCS Yearly Profit, Operating, Gross MarginsHSCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

5

2. Health

2.1 Basic Checks

HSCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HSCS has more shares outstanding
Compared to 5 years ago, HSCS has less shares outstanding
HSCS has a worse debt/assets ratio than last year.
HSCS Yearly Shares OutstandingHSCS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
HSCS Yearly Total Debt VS Total AssetsHSCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

HSCS has an Altman-Z score of -19.25. This is a bad value and indicates that HSCS is not financially healthy and even has some risk of bankruptcy.
HSCS has a Altman-Z score of -19.25. This is amonst the worse of the industry: HSCS underperforms 87.77% of its industry peers.
HSCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.25
ROIC/WACCN/A
WACC8.09%
HSCS Yearly LT Debt VS Equity VS FCFHSCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

A Current Ratio of 1.47 indicates that HSCS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.47, HSCS is doing worse than 77.66% of the companies in the same industry.
A Quick Ratio of 1.25 indicates that HSCS should not have too much problems paying its short term obligations.
The Quick ratio of HSCS (1.25) is worse than 65.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.25
HSCS Yearly Current Assets VS Current LiabilitesHSCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

HSCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.48%, which is quite impressive.
The Revenue for HSCS has decreased by -76.34% in the past year. This is quite bad
HSCS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -41.50% yearly.
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.15%
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.73% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y30.91%
EPS Next 2Y22.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HSCS Yearly Revenue VS EstimatesHSCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2027 500K 1M 1.5M
HSCS Yearly EPS VS EstimatesHSCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HSCS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSCS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HSCS Price Earnings VS Forward Price EarningsHSCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSCS Per share dataHSCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

HSCS's earnings are expected to grow with 22.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.73%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HSCS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTSCIENCES INC

NASDAQ:HSCS (11/18/2025, 4:30:01 PM)

3.03

+0.03 (+1.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-11 2025-09-11/amc
Earnings (Next)12-11 2025-12-11
Inst Owners2.33%
Inst Owner Change190.2%
Ins Owners1.67%
Ins Owner Change-16.78%
Market Cap9.30M
Revenue(TTM)6.30K
Net Income(TTM)-8.77M
Analysts82.5
Price Target13.77 (354.46%)
Short Float %0.69%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)18.08%
Max EPS beat(2)18.47%
EPS beat(4)3
Avg EPS beat(4)9.66%
Min EPS beat(4)-6.31%
Max EPS beat(4)18.47%
EPS beat(8)4
Avg EPS beat(8)-46.62%
EPS beat(12)7
Avg EPS beat(12)-29.34%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.33%
EPS NY rev (1m)0%
EPS NY rev (3m)14.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1476.52
P/FCF N/A
P/OCF N/A
P/B 2.96
P/tB 6.1
EV/EBITDA N/A
EPS(TTM)-8.3
EYN/A
EPS(NY)-4.62
Fwd EYN/A
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)-2.39
OCFYN/A
SpS0
BVpS1.02
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -136.22%
ROE -279.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.14%
FCFM N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.07%
Cap/Sales 479.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.25
Altman-Z -19.25
F-Score2
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)199.15%
Cap/Depr(5y)121.34%
Cap/Sales(3y)570.65%
Cap/Sales(5y)345.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.15%
EPS Next Y30.91%
EPS Next 2Y22.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.93%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTSCIENCES INC / HSCS FAQ

What is the fundamental rating for HSCS stock?

ChartMill assigns a fundamental rating of 2 / 10 to HSCS.


What is the valuation status of HEARTSCIENCES INC (HSCS) stock?

ChartMill assigns a valuation rating of 1 / 10 to HEARTSCIENCES INC (HSCS). This can be considered as Overvalued.


What is the profitability of HSCS stock?

HEARTSCIENCES INC (HSCS) has a profitability rating of 1 / 10.


How financially healthy is HEARTSCIENCES INC?

The financial health rating of HEARTSCIENCES INC (HSCS) is 5 / 10.